ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

ClinicalTrials.gov ID: NCT06516965

Public ClinicalTrials.gov record NCT06516965. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 9:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis

Study identification

NCT ID
NCT06516965
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Incyte Corporation
Industry
Enrollment
346 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Povorcitinib Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 9, 2024
Primary completion
Oct 18, 2026
Completion
May 2, 2027
Last update posted
Apr 13, 2026

2024 – 2027

United States locations

U.S. sites
28
U.S. states
16
U.S. cities
27
Facility City State ZIP Site status
Medical Dermatology Specialists Phoenix Phoenix Arizona 85006
Investigate Md Scottsdale Arizona 85255
First Oc Dermatology Research Inc Fountain Valley California 92708-3701
Clinical Science Institute Clinical Research Specialists Inc Santa Monica California 90404
Center For Clinical and Cosmetic Research Aventura Florida 33180
Schweiger Dermatology Boca Raton Florida 33428
Direct Helpers Research Center Hialeah Florida 33012
Skin Care Research, Llc Hollywood Florida 33201
Ziaderm Research, Llc Miami Florida 33162
Nodal Medical Center, Llc Tampa Florida 33607
Trueblue Clinical Research Moore Clinical Research, Inc McR Tampa Clinic Location Tampa Florida 33609
Dermatology Specialists Research Louisville Kentucky 40241
University of Maryland School of Medicine Baltimore Maryland 21201
Dermatology Associates Pc Rockville Maryland 20850
Metro Boston Clinical Partners Brighton Massachusetts 02135-3511
Fivenson Dermatology Ann Arbor Michigan 48103
Henry Ford Health System Detroit Michigan 48202
Michigan Dermatology Institute Waterford Michigan 48328
Allcutis Research, Llc Portsmouth New Hampshire 03801
Schweiger Dermatology Hackensack New Jersey 07601
OPTISKIN New York New York 10128
University of Cincinnati Cancer Institute Cincinnati Ohio 45267
Central Sooner Research Oklahoma City Oklahoma 73118
Paddington Testing Co Inc Philadelphia Pennsylvania 19103
Yardley Dermatology Associates Yardley Pennsylvania 19067
Modern Research Associates Pllc Dallas Texas 75231
University of Utah Midvalley Dermatology Murray Utah 84107
Aesthetic General Dermatology of Seattle Burien Washington 98168

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 91 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06516965, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06516965 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →